Home › Asthma › New Jersey
Asthma clinical trials in New Jersey
8 studies for Asthma are looking for participants at sites in New Jersey.
Cities in New Jersey
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
- Research Site, Millville
- Research Site, Toms River
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 25, 2026 · NCT06932263Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment
- Research Site, Northfield
RecruitingPhase 3
Ages 6 and older · All sexes · Updated Sep 22, 2026 · NCT07444567A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
- Rutgers, Robert Wood Johnson Medical School, New Brunswick
- Circuit Clinical / Impact Medical Allergy, Asthma & Immunology, Riverdale
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Sep 22, 2026 · NCT06977581A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
- Research Site, Northfield
RecruitingPhase 3
Ages 5 to 11 · All sexes · Updated Sep 21, 2026 · NCT06023589A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
- Teva Investigational Site 12110, Jersey City
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Aug 31, 2026 · NCT06664619Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
- Research Site, Newark
- Research Site, Northfield
- Research Site, Ocean City
- and 1 more
RecruitingPhase 3
Ages 12 to 17 · All sexes · Updated Aug 13, 2026 · NCT06307665Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
- GSK Investigational Site, New Brunswick
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jul 2, 2026 · NCT06979323Individualizing Treatment for Asthma in Primary Care (Full Study)
- Rutgers Robert Wood Johnson Medical School, New Brunswick
RecruitingPhase 4
Ages 13 to 75 · All sexes · Updated Oct 29, 2025 · NCT07052942From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.